{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:38:35Z","timestamp":1792201115034,"version":"4.4.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1053\/j.semnuclmed.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T21:11:16Z","timestamp":1739826676000},"page":"406-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Artificial Intelligence for Drug Discovery: An Update and Future Prospects"],"prefix":"10.1053","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-1588","authenticated-orcid":false,"given":"Harrison J.","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"McGale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Choucair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-0620","authenticated-orcid":false,"given":"Dorsa","family":"Shirini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Postow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-7790","authenticated-orcid":false,"given":"Mickael","family":"Tordjman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-1094","authenticated-orcid":false,"given":"Egesta","family":"Lopci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Lecler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-2118","authenticated-orcid":false,"given":"St\u00e9phane","family":"Champiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"Deandreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Dercle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0001","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0002","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41596-021-00659-2","article-title":"Artificial intelligence\u2013enabled virtual screening of ultra-large chemical libraries with deep docking","volume":"17","author":"Gentile","year":"2022","journal-title":"Nat Protoc"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0003","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s42256-022-00557-6","article-title":"Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework","volume":"4","author":"Zeng","year":"2022","journal-title":"Nat Mach Intel"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0004","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: An imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1053\/j.semnuclmed.2025.01.004_bib0005","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.3390\/diagnostics13193065","article-title":"Artificial intelligence and radiomics: Clinical applications for patients with advanced melanoma treated with immunotherapy","volume":"13","author":"McGale","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0006","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jtho.2022.12.019","article-title":"Baseline radiomic signature to estimate overall survival in patients with NSCLC","volume":"18","author":"Dercle","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamaoncol.2021.6818","article-title":"Early readout on overall survival of patients with melanoma treated with immunotherapy using a novel imaging analysis","volume":"8","author":"Dercle","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2021.10.029","article-title":"An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans","volume":"161","author":"Dercle","year":"2022","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0009","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1158\/1078-0432.CCR-19-2942","article-title":"Identification of non-small cell lung cancer sensitive to systemic cancer therapies using radiomics","volume":"26","author":"Dercle","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0010","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/jnci\/djaa017","article-title":"Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway","volume":"112","author":"Dercle","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0011","doi-asserted-by":"crossref","first-page":"101614","DOI":"10.1016\/j.arr.2022.101614","article-title":"Artificial intelligence in brain MRI analysis of Alzheimer's disease over the past 12 years: A systematic review","volume":"77","author":"Frizzell","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0012","doi-asserted-by":"crossref","first-page":"110887","DOI":"10.1016\/j.ejrad.2023.110887","article-title":"The role of AI in prostate MRI quality and interpretation: Opportunities and challenges","volume":"165","author":"Kim","year":"2023","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.01.004_bib0013","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/jmri.29358","article-title":"AI Applications to breast MRI: Today and tomorrow","volume":"60","author":"Lo Gullo","year":"2024","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0014","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1007\/s00330-024-10637-3","article-title":"Artificial intelligence in immunotherapy PET\/SPECT imaging","volume":"34","author":"McGale","year":"2024","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/ph17020210","article-title":"Integrating artificial intelligence and PET imaging for drug discovery: A paradigm shift in immunotherapy","volume":"17","author":"McGale","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0016","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10278-020-00332-2","article-title":"Predicting the response to FOLFOX-based chemotherapy regimen from untreated liver metastases on baseline CT: a deep neural network approach","volume":"33","author":"Maaref","year":"2020","journal-title":"J Digit Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mp.14563","article-title":"Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases","volume":"48","author":"Wei","year":"2021","journal-title":"Med Phys"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0018","doi-asserted-by":"crossref","first-page":"104235","DOI":"10.1016\/j.critrevonc.2023.104235","article-title":"Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging","volume":"194","author":"Liu","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0019","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12032-023-02184-6","article-title":"Recent advancement in targeted therapy and role of emerging technologies to treat cancer","volume":"40","author":"Barot","year":"2023","journal-title":"Med Oncol (Northwood, Lndn, Engl)"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0020","doi-asserted-by":"crossref","first-page":"1446961","DOI":"10.3389\/fimmu.2024.1446961","article-title":"Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma","volume":"15","author":"Fang","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0021","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0022","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1","volume":"23","author":"Champiat","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0023","doi-asserted-by":"crossref","first-page":"103531","DOI":"10.1016\/j.critrevonc.2021.103531","article-title":"Pseudoprogression in lung cancer patients treated with immunotherapy","volume":"169","author":"Chen","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1148\/radiol.210518","article-title":"Emerging and evolving concepts in cancer immunotherapy imaging","volume":"306","author":"Dercle","year":"2023","journal-title":"Radiology"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jmir.2019.08.006","article-title":"Intelligent imaging: Radiomics and artificial neural networks in heart failure","volume":"50","author":"Currie","year":"2019","journal-title":"J Med Imaging Radiat Sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0026","doi-asserted-by":"crossref","first-page":"26898","DOI":"10.1038\/s41598-024-77269-x","article-title":"Leveraging calcium score CT radiomics for heart failure risk prediction","volume":"14","author":"Singh","year":"2024","journal-title":"Sci Rep."},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0027","first-page":"1","article-title":"From immunology to artificial intelligence: Revolutionizing latent tuberculosis infection diagnosis with machine learning","volume":"10","author":"Li","year":"2023","journal-title":"Mil Med Res"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0028","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/jpm11090926","article-title":"A systematic review on the contribution of artificial intelligence in the development of medicines for COVID-2019","volume":"11","author":"Pires","year":"2021","journal-title":"J Persona Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.annonc.2023.10.125","article-title":"Artificial intelligence for predictive biomarker discovery in immuno-oncology: A systematic review","volume":"35","author":"Prelaj","year":"2024","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/tomography8010028","article-title":"AI-radiomics can improve inclusion criteria and clinical trial performance","volume":"8","author":"Tomaszewski","year":"2022","journal-title":"Tomography"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0031","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.11.008","article-title":"Artificial intelligence for prediction of response to cancer immunotherapy","volume":"87","author":"Yang","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.01.004_bib0032","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3390\/cancers16101832","article-title":"Implementation of artificial intelligence in personalized prognostic assessment of lung cancer: A narrative review","volume":"16","author":"Lococo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0033","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/EDBK_201441","article-title":"Tumor response assessment for precision cancer therapy: Response evaluation criteria in solid tumors and beyond","volume":"38","author":"Nishino","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00259-017-3695-3","article-title":"Molecularly targeted therapies in cancer: A guide for the nuclear medicine physician","volume":"44","author":"Lheureux","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"10.1053\/j.semnuclmed.2025.01.004_bib0035","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.01.004_bib0036","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2214\/AJR.09.3456","article-title":"Morphology, Attenuation, Size, and Structure (MASS) criteria: Assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy","volume":"194","author":"Smith","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0037","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-017-3687-3","article-title":"Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments","volume":"44","author":"Pinker","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0038","doi-asserted-by":"crossref","first-page":"e232674","DOI":"10.1148\/radiol.232674","article-title":"Liquid biopsy versus CT: Comparison of tumor burden quantification in 1065 patients with metastases","volume":"313","author":"Dawi","year":"2024","journal-title":"Radiology"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0039","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00259-019-04592-1","article-title":"Value of pre-therapy 18F-FDG PET\/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer","volume":"47","author":"Zhang","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"18","key":"10.1053\/j.semnuclmed.2025.01.004_bib0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma","volume":"391","author":"Blank","year":"2024","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0041","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1148\/radiol.2020192056","article-title":"Performance of CT compared with F-FDG PET in predicting the efficacy of nivolumab in relapsed or refractory Hodgkin lymphoma","volume":"295","author":"Mokrane","year":"2020","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0042","article-title":"Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns of acquired resistance to immunotherapy in patients with NSCLC","volume":"13","author":"Mazzaschi","year":"2024","journal-title":"Clin Ca Res: Offic J Am Assoc Ca Res"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0043","doi-asserted-by":"crossref","first-page":"e007628","DOI":"10.1136\/jitc-2023-007628","article-title":"Total metabolic tumor volume on 18F-FDG PET\/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy","volume":"12","author":"Tricarico","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"supplement 2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0044","article-title":"Role of FDG PET based metabolic tumor volume (MTV) in prognostication of locally advanced gallbladder carcinoma","volume":"63","author":"Pande","year":"2022","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cllc.2021.03.001","article-title":"The value of 18F-FDG PET\/CT in predicting the response to PD-1 blocking immunotherapy in advanced NSCLC patients with high-level PD-L1 expression","volume":"22","author":"Vekens","year":"2021","journal-title":"Clin Lung Ca"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0046","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/life13041051","article-title":"Assessment of the association between entropy in PET\/CT and response to Anti-PD-1\/PD-L1 monotherapy in stage III or IV NSCLC","volume":"13","author":"Malet","year":"2023","journal-title":"Life"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-00426-y","article-title":"PET radiomics in NSCLC: state of the art and a proposal for harmonization of methodology","volume":"7","author":"Sollini","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0048","doi-asserted-by":"crossref","first-page":"ix38","DOI":"10.1093\/annonc\/mdz421.031","article-title":"18F-FDG PET\/CT textural features as predictors of outcomes in patients with primary advanced colorectal cancer","volume":"30","author":"Yang","year":"2019","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.01.004_bib0049","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2214\/AJR.18.19796","article-title":"Tumor heterogeneity on FDG PET\/CT and immunotherapy: An imaging biomarker for predicting treatment response in patients with metastatic melanoma","volume":"212","author":"Sanli","year":"2019","journal-title":"Am J Roentgenol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0050","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3390\/cancers15082297","article-title":"Radiomics of tumor heterogeneity in 18F-FDG-PET-CT for predicting response to immune checkpoint inhibition in therapy-na\u00efve patients with advanced non-small-cell lung cancer","volume":"15","author":"Ventura","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0051","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-018-07131-y","article-title":"Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer","volume":"9","author":"Niemeijer","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0052","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.119.226712","article-title":"PET imaging of tumor PD-L1 expression with a highly specific nonblocking single-domain antibody","volume":"61","author":"Lv","year":"2020","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0053","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2967\/jnumed.121.262967","article-title":"Optimizing immuno-PET imaging of tumor PD-L1 expression: Pharmacokinetic, biodistribution, and dosimetric comparisons of 89Zr-labeled anti-PD-L1 antibody formats","volume":"63","author":"Bouleau","year":"2022","journal-title":"J Nucl Med: Offic Publ, Soc Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0054","doi-asserted-by":"crossref","first-page":"e000550","DOI":"10.1136\/jitc-2020-000550","article-title":"Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker","volume":"8","author":"He","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1148\/radiol.2021200928","article-title":"A CT-based radiomics signature is associated with response to immune checkpoint inhibitors in advanced solid tumors","volume":"299","author":"Ligero","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-019-0542-5","article-title":"Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence","volume":"9","author":"Sinigaglia","year":"2019","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0057","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41523-021-00252-6","article-title":"Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort","volume":"7","author":"Grinda","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0058","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2020.06.026","article-title":"A validated T cell radiomics score is associated with clinical outcomes following multisite SBRT and pembrolizumab","volume":"108","author":"Korpics","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0059","first-page":"743","article-title":"A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1\/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer","volume":"13","author":"Yang","year":"2021","journal-title":"Am J Transl Res"},{"issue":"7637","key":"10.1053\/j.semnuclmed.2025.01.004_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005292","article-title":"Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy","volume":"10","author":"Dercle","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0062","doi-asserted-by":"crossref","first-page":"k793","DOI":"10.1136\/bmj.k793","article-title":"Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: Systematic review and meta-analysis","volume":"360","author":"Baxi","year":"2018","journal-title":"BMJ"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0063","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41573-022-00538-9","article-title":"The expanding role for small molecules in immuno-oncology","volume":"21","author":"Offringa","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0064","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41569-021-00527-2","article-title":"Applications of artificial intelligence in cardiovascular imaging","volume":"18","author":"Sermesant","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s42256-019-0019-2","article-title":"Deep learning cardiac motion analysis for human survival prediction","volume":"1","author":"Bello","year":"2019","journal-title":"Nat Mach Intell"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0066","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1148\/radiol.2019182304","article-title":"Deep learning for diagnosis of chronic myocardial infarction on nonenhanced cardiac cine MRI","volume":"291","author":"Zhang","year":"2019","journal-title":"Radiology"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0067","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1109\/TMI.2019.2900516","article-title":"Deep learning for segmentation using an open large-scale dataset in 2D echocardiography","volume":"38","author":"Leclerc","year":"2019","journal-title":"IEEE Trans Med Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0068","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12968-019-0523-x","article-title":"Automated quality control in image segmentation: Application to the UK Biobank cardiovascular magnetic resonance imaging study","volume":"21","author":"Robinson","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0069","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1109\/JBHI.2019.2948316","article-title":"A generic quality control framework for fetal ultrasound cardiac four-chamber planes","volume":"24","author":"Dong","year":"2020","journal-title":"IEEE J Biomed Health Inform"},{"issue":"2 Pt 1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jcmg.2019.09.015","article-title":"Evaluation of a deep learning-based automated CT coronary artery calcium scoring algorithm","volume":"13","author":"Martin","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0071","first-page":"7292","article-title":"Classification of LV wall motion in cardiac MRI using kernel Dictionary Learning with a parametric approach","volume":"2015","author":"Mantilla","year":"2015","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0072","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1109\/TMI.2019.2953054","article-title":"Deep learning analysis of coronary arteries in cardiac CT angiography for detection of patients requiring invasive coronary angiography","volume":"39","author":"Zreik","year":"2020","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0073","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.eswa.2019.04.010","article-title":"Discriminative dictionary learning for local LV wall motion classification in cardiac MRI","volume":"129","author":"Mantilla","year":"2019","journal-title":"Exp Syst Appl"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0074","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13139-016-0433-x","article-title":"Recent advances in nuclear cardiology","volume":"50","author":"Lee","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"issue":"18","key":"10.1053\/j.semnuclmed.2025.01.004_bib0075","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/electronics10182230","article-title":"CZT detectors-based SPECT imaging: how detector and collimator arrangement can determine the overall performance of the tomograph","volume":"10","author":"Santarelli","year":"2021","journal-title":"Electronics"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0076","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/diagnostics11112130","article-title":"Capabilities of modern semiconductor gamma cameras in radionuclide diagnosis of coronary artery disease","volume":"11","author":"B\u0142aszczyk","year":"2021","journal-title":"Diagnostics"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0077","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ehjci\/jev312","article-title":"Diagnostic accuracy of cadmium-zinc-telluride-based myocardial perfusion SPECT: impact of attenuation correction using a co-registered external computed tomography","volume":"17","author":"Caobelli","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0078","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-013-9827-7","article-title":"Diagnostic performance of low-dose rest\/stress Tc-99m tetrofosmin myocardial perfusion SPECT using the 530c CZT camera: quantitative vs visual analysis","volume":"21","author":"Esteves","year":"2014","journal-title":"J Nucl Cardiol: Offic Publ Am Soc Nucl Cardiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0079","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s12350-020-02376-x","article-title":"Diagnostic performance of prone-only myocardial perfusion imaging versus coronary angiography in the detection of coronary artery disease: A systematic review and meta-analysis","volume":"29","author":"Mirshahvalad","year":"2022","journal-title":"J Nucl Cardiol: Offic Publ Am Soc Nucl Cardiol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.01.004_bib0080","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2967\/jnumed.118.220657","article-title":"Solid-state detector SPECT myocardial perfusion imaging","volume":"60","author":"Slomka","year":"2019","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0081","first-page":"1847","article-title":"Contemporary Cardiac SPECT imaging\u2014innovations and best practices: An information statement from the american society of nuclear cardiology","volume":"25","author":"Abbott","year":"2018","journal-title":"Circ: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0082","first-page":"100126","article-title":"Artificial intelligence and imaging: Opportunities in cardio-oncology","volume":"15","author":"Madan","year":"2022","journal-title":"Am Heart J Plus"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0083","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s10554-020-01935-0","article-title":"Fully automated quantification of left ventricular volumes and function in cardiac MRI: Clinical evaluation of a deep learning-based algorithm","volume":"36","author":"B\u00f6ttcher","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2025.01.004_bib0084","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jcmg.2017.07.024","article-title":"Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning","volume":"11","author":"Betancur","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"24","key":"10.1053\/j.semnuclmed.2025.01.004_bib0085","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/CIRCULATIONAHA.120.048708","article-title":"Immune checkpoint inhibitor therapy induces inflammatory activity in large arteries","volume":"142","author":"Calabretta","year":"2020","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0086","doi-asserted-by":"crossref","first-page":"e68714","DOI":"10.7554\/eLife.68714","article-title":"Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Grafton","year":"2021","journal-title":"eLife"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0087","first-page":"100129","article-title":"Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography","volume":"15","author":"Martinez","year":"2022","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.01.004_bib0088","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/jpm11100993","article-title":"Artificial intelligence and COVID-19 using chest CT scan and chest X-ray images: Machine learning and deep learning approaches for diagnosis and treatment","volume":"11","author":"Fusco","year":"2021","journal-title":"J Pers Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-51053-9","article-title":"An AI-based novel system for predicting respiratory support in COVID-19 patients through CT imaging analysis","volume":"14","author":"Farahat","year":"2024","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0090","doi-asserted-by":"crossref","first-page":"105467","DOI":"10.1016\/j.compbiomed.2022.105467","article-title":"COVID-19 prognostic modeling using CT radiomic features and machine learning algorithms: Analysis of a multi-institutional dataset of 14,339 patients","volume":"145","author":"Shiri","year":"2022","journal-title":"Comput Biol Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.01.004_bib0091","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.7150\/ijms.48432","article-title":"A Quantitative and Radiomics approach to monitoring ARDS in COVID-19 patients based on chest CT: A retrospective cohort study","volume":"17","author":"Chen","year":"2020","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0092","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jmrs.631","article-title":"Prediction of COVID-19 patients in danger of death using radiomic features of portable chest radiographs","volume":"70","author":"Nakashima","year":"2023","journal-title":"J Med Radiat Sci"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0093","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mayocpiqo.2023.03.001","volume":"7","author":"Zaazoue","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0094","series-title":"TP88. TP088 LUCY IN THE SKY WITH DIAMONDS - PULMONARY EMBOLISM, CTEPH, THROMBOSIS, AND COVID19: CLINICAL ADVANCES","article-title":"Artificial intelligence to optimize pulmonary embolism diagnosis during covid-19 pandemic by perfusion SPECT\/CT, a pilot study","author":"Baeza Mena","year":"2021"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semnuclmed.2021.06.017","article-title":"FDG-PET\/CT of COVID-19 and other lung infections","volume":"52","author":"Eibschutz","year":"2022","journal-title":"Semin Nucl Med"},{"issue":"supplement 2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0096","article-title":"A prospective study to investigate the implementation of semiquantitative inflammatory load in post-COVID-19 lung disease (PCLD) to strategize therapy","volume":"63","author":"Khandelwal","year":"2022","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0097","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1038\/s41598-021-86114-4","article-title":"Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"16","key":"10.1053\/j.semnuclmed.2025.01.004_bib0098","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.3390\/jcm12165432","article-title":"Radiomics and artificial intelligence for the diagnosis and monitoring of Alzheimer's disease: A systematic review of studies in the field","volume":"12","author":"Bevilacqua","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0099","first-page":"514","article-title":"Radiomics-based artificial intelligence differentiation of neurodegenerative diseases with reference to the volumetry","volume":"12","author":"Cheung","year":"2022","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/diagnostics12040933","article-title":"Radiomics analysis of brain [F]FDG PET\/CT to predict alzheimer's disease in patients with amyloid PET positivity: A preliminary report on the application of SPM cortical segmentation, pyradiomics and machine-learning analysis","volume":"12","author":"Alongi","year":"2022","journal-title":"Diagnos (Basel)"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0101","doi-asserted-by":"crossref","first-page":"101379","DOI":"10.1016\/j.xcrm.2023.101379","article-title":"Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease","volume":"5","author":"Cheng","year":"2024","journal-title":"Cell Rep Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2025.01.004_bib0102","first-page":"1561","article-title":"One step forward-the current role of artificial intelligence in glioblastoma imaging","volume":"13","author":"Chirica","year":"2023","journal-title":"Life (Basel)"},{"issue":"18","key":"10.1053\/j.semnuclmed.2025.01.004_bib0103","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.3390\/cancers15184429","article-title":"Radiomics: The new promise for differentiating progression, recurrence, pseudoprogression, and radionecrosis in glioma and glioblastoma multiforme","volume":"15","author":"Alizadeh","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0104","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3390\/curroncol30030203","article-title":"Artificial intelligence in brain tumor imaging: A step toward personalized medicine","volume":"30","author":"C\u00e8","year":"2023","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12873-019-0262-1","article-title":"Diagnostic accuracy of clinical tools for assessment of acute stroke: a systematic review","volume":"19","author":"Antipova","year":"2019","journal-title":"BMC Emerg Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0106","first-page":"e59768","article-title":"The role of artificial intelligence-powered imaging in cerebrovascular accident detection","volume":"16","author":"Hastings","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0107","doi-asserted-by":"crossref","first-page":"e0279088","DOI":"10.1371\/journal.pone.0279088","article-title":"Expectations and attitudes towards medical artificial intelligence: A qualitative study in the field of stroke","volume":"18","author":"Amann","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0108","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5853\/jos.2017.02054","article-title":"Deep into the brain: Artificial intelligence in stroke imaging","volume":"19","author":"Lee","year":"2017","journal-title":"J Stroke"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01586-2","article-title":"An interpretable multiparametric radiomics model for the diagnosis of schizophrenia using magnetic resonance imaging of the corpus callosum","volume":"11","author":"Bang","year":"2021","journal-title":"Transl Psychiat"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-016-0001-5","article-title":"Personalized medicine for schizophrenia","volume":"3","author":"Buckley","year":"2017","journal-title":"npj Schizophrenia"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0111","doi-asserted-by":"crossref","first-page":"1328687","DOI":"10.3389\/fmed.2024.1328687","article-title":"Radiomics analysis of pancreas based on dual-energy computed tomography for the detection of type 2 diabetes mellitus","volume":"11","author":"Jiang","year":"2024","journal-title":"Front Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0112","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1007\/s00261-022-03668-1","article-title":"Radiomics-based machine learning (ML) classifier for detection of type 2 diabetes on standard-of-care abdomen CTs: a proof-of-concept study","volume":"47","author":"Wright","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0113","doi-asserted-by":"crossref","first-page":"922299","DOI":"10.3389\/fmed.2022.922299","article-title":"Radiomics and its applications and progress in pancreatitis: A current state of the art review","volume":"9","author":"Yan","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"18","key":"10.1053\/j.semnuclmed.2025.01.004_bib0114","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40744-022-00475-4","article-title":"Artificial intelligence in rheumatoid arthritis: Current status and future perspectives: A state-of-the-art review","volume":"9","author":"Momtazmanesh","year":"2022","journal-title":"Rheumatol Ther"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0116","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/rheumatology\/keae092","article-title":"Artificial intelligence and machine learning in rheumatology","volume":"63","author":"Dubey","year":"2024","journal-title":"Rheumatol (Oxford, Engl"},{"issue":"13","key":"10.1053\/j.semnuclmed.2025.01.004_bib0117","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1245\/s10434-024-15373-y","article-title":"Computed tomography-based radiomics with machine learning outperforms radiologist assessment in estimating colorectal liver metastases pathologic response after chemotherapy","volume":"31","author":"Karagkounis","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0118","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1148\/radiol.210551","article-title":"Deep learning reconstruction shows better lung nodule detection for ultra-low-dose chest CT","volume":"303","author":"Jiang","year":"2022","journal-title":"Radiology"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0119","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s00261-023-03966-2","article-title":"Deep-learning CT reconstruction in clinical scans of the abdomen: A systematic review and meta-analysis","volume":"48","author":"Shehata","year":"2023","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0120","doi-asserted-by":"crossref","first-page":"e4225","DOI":"10.1002\/nbm.4225","article-title":"Suppressing motion artefacts in MRI using an Inception-ResNet network with motion simulation augmentation","volume":"35","author":"Pawar","year":"2022","journal-title":"NMR in Biomed"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejmp.2019.04.009","article-title":"Stability of radiomic features of apparent diffusion coefficient (ADC) maps for locally advanced rectal cancer in response to image pre-processing","volume":"61","author":"Traverso","year":"2019","journal-title":"Phys Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0122","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1038\/s41598-019-45766-z","article-title":"Repeatability of multiparametric prostate MRI radiomics features","volume":"9","author":"Schwier","year":"2019","journal-title":"Sci Rep."},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0123","doi-asserted-by":"crossref","first-page":"e0213459","DOI":"10.1371\/journal.pone.0213459","article-title":"Gray-level discretization impacts reproducible MRI radiomics texture features","volume":"14","author":"Duron","year":"2019","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0124","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejmp.2018.05.017","article-title":"Evaluation of radiomic texture feature error due to MRI acquisition and reconstruction: A simulation study utilizing ground truth","volume":"50","author":"Yang","year":"2018","journal-title":"Phys Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuroimage.2005.09.046","article-title":"Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data","volume":"30","author":"Jovicich","year":"2006","journal-title":"Neuroimage"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12880-021-00699-w","article-title":"Impact of time of flight and point spread function on quantitative parameters of lung lesions in 18F-FDG PET\/CT","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Med Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0127","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2478\/raon-2022-0015","article-title":"Image reconstruction using small-voxel size improves small lesion detection for positron emission tomography","volume":"56","author":"Rep","year":"2022","journal-title":"Radiol Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.semnuclmed.2021.10.005","article-title":"Advances in PET\/CT technology: An update","volume":"52","author":"Aide","year":"2022","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.semnuclmed.2024.07.003","article-title":"Total-Body PET\/CT: Pros and cons","volume":"55","author":"Hicks","year":"2025","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41824-022-00158-x","article-title":"Volumetric parameters of the primary tumor and whole-body tumor burden derived from baseline 18F-FDG PET\/CT can predict overall survival in non-small cell lung cancer patients: Initial results from a single institution","volume":"6","author":"Mahmoud","year":"2022","journal-title":"Eur J Hybrid Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0131","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.spinee.2024.09.012","article-title":"Incorporation of whole-body metabolic tumor burden into current prognostic models for nonsmall cell lung cancer patients with spine metastasis","volume":"25","author":"Hong","year":"2025","journal-title":"Spine J"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0132","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2967\/jnumed.121.262464","article-title":"A guide to combat harmonization of imaging biomarkers in multicenter studies","volume":"63","author":"Orlhac","year":"2022","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.01.004_bib0133","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.semnuclmed.2015.06.002","article-title":"Technical pitfalls and limitations of SPECT\/CT","volume":"45","author":"Livieratos","year":"2015","journal-title":"Semin Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.01.004_bib0134","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2967\/jnumed.123.266889","article-title":"A deep-learning\u2013based partial-volume correction method for quantitative 177Lu SPECT\/CT imaging","volume":"65","author":"Leube","year":"2024","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0135","doi-asserted-by":"crossref","first-page":"e000262","DOI":"10.1136\/fmch-2019-000262","article-title":"Variable selection strategies and its importance in clinical prediction modelling","volume":"8","author":"Chowdhury","year":"2020","journal-title":"Fam Med Commun Health"},{"issue":"13","key":"10.1053\/j.semnuclmed.2025.01.004_bib0136","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s00259-019-04414-4","article-title":"AI-based applications in hybrid imaging: How to build smart and truly multi-parametric decision models for radiomics","volume":"46","author":"Castiglioni","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.01.004_bib0137","doi-asserted-by":"crossref","first-page":"e210097","DOI":"10.1148\/ryai.2021210097","article-title":"Toward generalizability in the deployment of artificial intelligence in radiology: Role of computation stress testing to overcome underspecification","volume":"3","author":"Eche","year":"2021","journal-title":"Radiol Artific Intell"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.01.004_bib0138","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2025.01.004_bib0139","first-page":"e101","article-title":"Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials","volume":"49","author":"Shukla-Dave","year":"2018","journal-title":"J Magnet Resonan Imaging: JMRI"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13244-019-0764-0","article-title":"Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR)","volume":"10","author":"deSouza","year":"2019","journal-title":"Insights Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0141","doi-asserted-by":"crossref","first-page":"e231319","DOI":"10.1148\/radiol.231319","article-title":"The image biomarker standardization initiative: standardized convolutional filters for reproducible radiomics and enhanced clinical insights","volume":"310","author":"Whybra","year":"2024","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0142","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0143","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41598-023-50451-3","article-title":"Comparative analysis of radiomics and deep-learning algorithms for survival prediction in hepatocellular carcinoma","volume":"14","author":"Sch\u00f6n","year":"2024","journal-title":"Sci Rep."},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0144","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0145","doi-asserted-by":"crossref","first-page":"e23421","DOI":"10.7554\/eLife.23421","article-title":"Defining the biological basis of radiomic phenotypes in lung cancer","volume":"6","author":"Grossmann","year":"2017","journal-title":"Elife"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.01.004_bib0146","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.7150\/thno.15253","article-title":"High-resolution PET imaging with therapeutic antibody-based PD-1\/PD-L1 checkpoint tracers","volume":"6","author":"Hettich","year":"2016","journal-title":"Theranostics"},{"issue":"7","key":"10.1053\/j.semnuclmed.2025.01.004_bib0147","doi-asserted-by":"crossref","first-page":"e1329071","DOI":"10.1080\/2162402X.2017.1329071","article-title":"Preclinical immunoPET\/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma","volume":"6","author":"Kikuchi","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0148","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2967\/jnumed.117.199596","article-title":"Synthesis and biologic evaluation of a novel 18F-labeled Adnectin as a PET radioligand for imaging PD-L1 expression","volume":"59","author":"Donnelly","year":"2018","journal-title":"J Nucl Med"},{"issue":"14","key":"10.1053\/j.semnuclmed.2025.01.004_bib0149","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/0008-5472.CAN-14-3477","article-title":"Noninvasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies","volume":"75","author":"Heskamp","year":"2015","journal-title":"Cancer Res"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.01.004_bib0150","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-018-0255-8","article-title":"89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer","volume":"24","author":"Bensch","year":"2018","journal-title":"Nat Med"},{"issue":"26","key":"10.1053\/j.semnuclmed.2025.01.004_bib0151","doi-asserted-by":"crossref","first-page":"41932","DOI":"10.18632\/oncotarget.16708","article-title":"Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers","volume":"8","author":"Broos","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0152","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2967\/jnmt.122.265272","article-title":"Whole-body imaging protocol for evaluating tumor estrogen receptor status in patients with recurrent or metastatic breast cancer","volume":"51","author":"Grabher","year":"2023","journal-title":"J Nucl Med Technol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0153","doi-asserted-by":"crossref","first-page":"e220143","DOI":"10.1148\/rg.220143","article-title":"F-Fluoroestradiol: Current applications and future directions","volume":"43","author":"O'Brien","year":"2023","journal-title":"Radiographics"},{"issue":"15","key":"10.1053\/j.semnuclmed.2025.01.004_bib0154","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.3390\/jcm12154882","article-title":"PET\/CT and SPECT\/CT imaging of HER2-positive breast cancer","volume":"12","author":"McGale","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nucmedbio.2012.08.004","article-title":"PET imaging with 89Zr: From radiochemistry to the clinic","volume":"40","author":"Deri","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0156","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2967\/jnumed.119.229781","article-title":"First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: Preliminary pharmacokinetics, biodistribution, and lesion targeting","volume":"61","author":"Pandit-Taskar","year":"2020","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0157","first-page":"720","article-title":"CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: A phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody","volume":"63","author":"Farwell","year":"2022","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.01.004_bib0158","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1073\/pnas.1316922111","article-title":"Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo","volume":"111","author":"Tavar\u00e9","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"npj Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41747-022-00282-0","article-title":"Radiomics and artificial intelligence in prostate cancer: New tools for molecular hybrid imaging and theragnostics","volume":"6","author":"Liberini","year":"2022","journal-title":"Eur Radiol Exp"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.01.004_bib0161","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/life13081647","article-title":"Applications of artificial intelligence and radiomics in molecular hybrid imaging and theragnostics for neuro-endocrine neoplasms (NENs)","volume":"13","author":"Balma","year":"2023","journal-title":"Life"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0162","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/diagnostics14020181","article-title":"Radiomics and artificial intelligence in radiotheranostics: A review of applications for radioligands targeting somatostatin receptors and prostate-specific membrane antigens","volume":"14","author":"Yazdani","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"supplement 2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0163","first-page":"2594","article-title":"SPECT\/CT using [99mTc]-labeled anti-programmed death-ligand 1 (PD-L1) single-domain antibody (NM-01) to predict response to immune checkpoint inhibition in non-small cell lung cancer: Preliminary results from the PD-L1 Expression in Cancer (PECan) study","volume":"63","author":"Hughes","year":"2022","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0164","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.3390\/cancers13112828","article-title":"Prospective SPECT-CT organ dosimetry-driven radiation-absorbed dose escalation using the In-111 (111In)\/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin\u00ae) Theranostic pair in patients with lymphoma at myeloablative dose levels","volume":"13","author":"Wahl","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.01.004_bib0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5001\/omj.2014.95","article-title":"111 In-pentetreotide SPECT CT value in follow-up of patients with neuro-endocrine tumors","volume":"29","author":"Al-Suqri","year":"2014","journal-title":"Oman Med J"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0166","first-page":"209","article-title":"Research applications of selected 123I-labeled neuroreceptor SPECT imaging ligands","volume":"32","author":"Ross","year":"2004","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-020-00650-0","article-title":"In vivo absolute quantification of striatal and extrastriatal D2\/3 receptors with [123I]epidepride SPECT","volume":"10","author":"Tsartsalis","year":"2020","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0168","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/med.20245","article-title":"5-HT radioligands for human brain imaging with PET and SPECT","volume":"33","author":"Paterson","year":"2013","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-3-12","article-title":"Multimodality imaging using SPECT\/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles","volume":"3","author":"Barrefelt","year":"2013","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-97302-7","article-title":"Simultaneous in vivo imaging with PET and SPECT tracers using a Compton-PET hybrid camera","volume":"11","author":"Uenomachi","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: The \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.01.004_bib0172","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3348\/kjr.2022.0225","article-title":"Evolution of radiological treatment response assessments for cancer immunotherapy: From IRECIST to radiomics and artificial intelligence","volume":"23","author":"Kim","year":"2022","journal-title":"Kor J Radiol"},{"issue":"17","key":"10.1053\/j.semnuclmed.2025.01.004_bib0173","article-title":"Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and\/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study","volume":"40","author":"Modi","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.01.004_bib0174","doi-asserted-by":"crossref","first-page":"e222646","DOI":"10.1148\/radiol.222646","article-title":"Multiparametric MRI and radiomics for the prediction of HER2-zero, -low, and -positive breast cancers","volume":"308","author":"Ramtohul","year":"2023","journal-title":"Radiology"},{"issue":"6_Supplement","key":"10.1053\/j.semnuclmed.2025.01.004_bib0175","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/1538-7445.AM2024-2587","article-title":"Abstract 2587: Evaluating the potential of radiomics features to predict outcome to an antibody-drug conjugate therapy in non-small cell lung cancer patients","volume":"84","author":"Chen","year":"2024","journal-title":"Ca Res"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0176","doi-asserted-by":"crossref","DOI":"10.1177\/1536012117745386","article-title":"Targeting HER2 in nuclear medicine for imaging and therapy","volume":"17","author":"Massicano","year":"2018","journal-title":"Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.01.004_bib0177","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jlcr.3465","article-title":"Preparation and preclinical evaluation of I-trastuzumab for breast cancer","volume":"60","author":"Kameswaran","year":"2017","journal-title":"J Labelled Comp Radiopharm"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.01.004_bib0178","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.nucmedbio.2009.01.015","article-title":"Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer","volume":"36","author":"Rasaneh","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.01.004_bib0179","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1053\/j.semnuclmed.2025.01.004_bib0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymeth.2020.07.003","article-title":"Reinventing radiation therapy with machine learning and imaging bio-markers (radiomics): State-of-the-art, challenges and perspectives","volume":"188","author":"Dercle","year":"2021","journal-title":"Methods (San Diego, Calif)"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:33:15Z","timestamp":1744677195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299825000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":180,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0001299825000042"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.01.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial Intelligence for Drug Discovery: An Update and Future Prospects","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}